4a medicom GmbH, with headquarters in Traboch (Austria) was established in 2006 with the aim of decisively simplifying the hitherto complicated self-monitoring of blood glucose (SMBG) Because many diabetics are required to monitor their own blood glucose levels several times each day, SMBG represent a large and still-growing market.
Unlike the conventional measurement methods in wide use today – methods involving multiple separate components – the product of 4a medicom GmbH integrates lancing device, lancet and test strips in a single device. This enables patients to measure blood glucose levels in a single step. Key benefits of the product are its practically pain free operation and ease of use. This is of great importance, particularly for the fast-growing group of older patients. Designed as a safety product, the device also offers effective protection against infection for hospital and clinic staff. Expansion of the device’s analytical capability to include other
blood parameters is planned.
4a medicom GmbH
Industriepark 1
A-8772 Traboch
Schoenbrunnerstrasse 218-220/A/4.04
A-1120 Vienna
Tel.: +43 (1) 513 10 72
Fax: +43 (1) 513 10 72-200
office@gamma-capital.com
www.gamma-capital.com